About AcureX
AcureX is a company based in San Carlos (United States) founded in 2019 by Xinnan Wang, William Sharder, and Lev Leytes.. AcureX offers products and services including CU-13001, M3D Platform, 15-Lipoxygenase, and Selective Ca V 3.2 T-Type Calcium. AcureX operates in a competitive market with competitors including UCB, Cellino, Aspen Neuroscience, Kenai Therapeutics and Shize Bio, among others.
- Headquarter San Carlos, United States
- Founders Xinnan Wang, William Sharder, Lev Leytes
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Acurex Biosciences Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
The Michael J. Fox Foundation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AcureX
AcureX offers a comprehensive portfolio of products and services, including CU-13001, M3D Platform, 15-Lipoxygenase, and Selective Ca V 3.2 T-Type Calcium. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral small molecule for treating Parkinson's Disease progression.
Tool for identifying druggable targets in neurological diseases.
Component in pipeline for neurodegenerative disease research.
Potential therapy element in neurology drug development.
Funding Insights of AcureX
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Grant - AcureX | Valuation |
investors |
|
| Oct, 2021 | Amount | Grant - AcureX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AcureX
AcureX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include The Michael J. Fox Foundation and The Silverstein Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research for Parkinson's disease is funded by the foundation.
|
Founded Year | Domain | Location | |
|
Funds cutting-edge research and programs for Parkinson's with GBA mutations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AcureX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AcureX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acurex Comparisons
Competitors of AcureX
AcureX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as UCB, Cellino, Aspen Neuroscience, Kenai Therapeutics and Shize Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of genomic-based personalised pluripotent stem cell therapy
|
|
| domain | founded_year | HQ Location |
Allogeneic cell therapies for neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Stem-cell therapies for neurodegenerative diseases are developed using gene editing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Acurex
Frequently Asked Questions about AcureX
When was AcureX founded?
AcureX was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is AcureX located?
AcureX is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
What does AcureX do?
AcureX was established in 2019 in San Carlos, United States, within the biotechnology sector. Disease-modifying therapies for Parkinsons disease are developed by the company as its primary operations. Miro1 is utilized as a clinical biomarker with potential to inhibit disease progression. Efforts are centered on advancing treatments for neurodegenerative conditions through research and development activities.
Who are the top competitors of AcureX?
AcureX's top competitors include UCB, Cellino and Aspen Neuroscience.
What products or services does AcureX offer?
AcureX offers CU-13001, M3D Platform, 15-Lipoxygenase, and Selective Ca V 3.2 T-Type Calcium.
Who are AcureX's investors?
AcureX has 2 investors. Key investors include The Michael J. Fox Foundation, and The Silverstein Foundation.